BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 15674090)

  • 1. Antibiotics for inflammatory bowel disease: do they work?
    Guslandi M
    Eur J Gastroenterol Hepatol; 2005 Feb; 17(2):145-7. PubMed ID: 15674090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of antibiotics for treatment of inflammatory bowel disease.
    Nitzan O; Elias M; Peretz A; Saliba W
    World J Gastroenterol; 2016 Jan; 22(3):1078-87. PubMed ID: 26811648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of inflammatory bowel disease: does rifaximin offer any promise?
    Gionchetti P; Rizzello F; Morselli C; Romagnoli R; Campieri M
    Chemotherapy; 2005; 51 Suppl 1():96-102. PubMed ID: 15855753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of antibiotics in the management of inflammatory bowel disease: a review.
    Rubin DT; Kornblunth A
    Rev Gastroenterol Disord; 2005; 5 Suppl 3():S10-5. PubMed ID: 17713454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rifaximin in the treatment of inflammatory bowel disease.
    Guslandi M
    World J Gastroenterol; 2011 Nov; 17(42):4643-6. PubMed ID: 22180705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review--antibiotic treatment in inflammatory bowel disease: rifaximin, a new possible approach.
    Gionchetti P; Rizzello F; Venturi A; Ugolini F; Rossi M; Brigidi P; Johansson R; Ferrieri A; Poggioli G; Campieri M
    Eur Rev Med Pharmacol Sci; 1999; 3(1):27-30. PubMed ID: 10710827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Manipulation of the bacterial flora in inflammatory bowel disease.
    Marteau P; Seksik P; Shanahan F
    Best Pract Res Clin Gastroenterol; 2003 Feb; 17(1):47-61. PubMed ID: 12617882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnosis and treatment of pouchitis in inflammatory bowel disease.
    Cheifetz A; Itzkowitz S
    J Clin Gastroenterol; 2004; 38(5 Suppl 1):S44-50. PubMed ID: 15115932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiota and inflammatory bowel disease.
    Hammer HF
    Dig Dis; 2011; 29(6):550-3. PubMed ID: 22179210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of anti(myco)bacterial interventions in the management of IBD: is there evidence at all?
    Pineton de Chambrun GP; Torres J; Darfeuille-Michaud A; Colombel JF
    Dig Dis; 2012; 30(4):358-67. PubMed ID: 22796797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of antibiotics in the treatment of inflammatory bowel disease.
    Perencevich M; Burakoff R
    Inflamm Bowel Dis; 2006 Jul; 12(7):651-64. PubMed ID: 16804403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of antibiotic and probiotic therapies in current and future management of inflammatory bowel disease.
    Ewaschuk JB; Tejpar QZ; Soo I; Madsen K; Fedorak RN
    Curr Gastroenterol Rep; 2006 Dec; 8(6):486-98. PubMed ID: 17105688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk-benefit assessment of drugs used in the treatment of inflammatory bowel disease.
    Hanauer SB; Stathopoulos G
    Drug Saf; 1991; 6(3):192-219. PubMed ID: 1676590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobials in the management of inflammatory bowel disease.
    Gionchetti P; Rizzello F; Lammers KM; Morselli C; Tambasco R; Campieri M
    Digestion; 2006; 73 Suppl 1():77-85. PubMed ID: 16498255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiota and inflammatory bowel disease: the role of antibiotics in disease management.
    Kerman DH; Deshpande AR
    Postgrad Med; 2014 Jul; 126(4):7-19. PubMed ID: 25141239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD).
    Biancone L; Annese V; Ardizzone S; Armuzzi A; Calabrese E; Caprioli F; Castiglione F; Comberlato M; Cottone M; Danese S; Daperno M; D'IncĂ  R; Frieri G; Fries W; Gionchetti P; Kohn A; Latella G; Milla M; Orlando A; Papi C; Petruzziello C; Riegler G; Rizzello F; Saibeni S; Scribano ML; Vecchi M; Vernia P; Meucci G;
    Dig Liver Dis; 2017 Apr; 49(4):338-358. PubMed ID: 28161290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics.
    Sartor RB
    Gastroenterology; 2004 May; 126(6):1620-33. PubMed ID: 15168372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotics for inflammatory bowel disease: Current status.
    Jha DK; Mishra S; Dutta U; Sharma V
    Indian J Gastroenterol; 2024 Feb; 43(1):145-159. PubMed ID: 38376725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of inflammatory bowel disease with antibiotics.
    Isaacs KL; Sartor RB
    Gastroenterol Clin North Am; 2004 Jun; 33(2):335-45, x. PubMed ID: 15177542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review article: the potential mechanisms of action of rifaximin in the management of inflammatory bowel diseases.
    Sartor RB
    Aliment Pharmacol Ther; 2016 Jan; 43 Suppl 1():27-36. PubMed ID: 26618923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.